|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 17 studies with search of: | Progressive Supranuclear Palsy |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy
|
||||
| 2 | Active, not recruiting |
A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration
|
||||
| 3 | Recruiting |
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
|
||||
| 4 | Recruiting |
Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy
|
||||
| 5 | Completed |
Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy
|
||||
| 6 | Active, not recruiting |
A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.
|
||||
| 7 | Recruiting |
Risk Factors for Progressive Supranuclear Palsy (PSP)
|
||||
| 8 | Completed |
Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy
|
||||
| 9 | Terminated |
Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)
|
||||
| 10 | Recruiting |
Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy
|
||||
| 11 | Active, not recruiting |
Diagnostic and Prognostic Biomarkers in Parkinson Disease
|
||||
| 12 | Completed |
Effects of Coenzyme Q10 in PSP and CBD
|
||||
| 13 | Not yet recruiting |
Research of Biomarkers in Parkinson Disease
|
||||
| 14 | Active, not recruiting |
Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
|
||||
| 15 | Completed |
Diagnosis and Natural History Study of Patients With Neurological Conditions
|
||||
| 16 | Completed |
Study of Tongue Pressures
|
||||
| 17 | Completed |
Study About Efficacy and Safety to Treat Multi-System-Atrophy
|